Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy

C. H. Lin, W. Zhang, T. W. Ng, D. Zhang, J. Jiang, B. Pulikkottil, F. Lakkis, V. S. Gorantla, W P Andrew Lee, Gerald Brandacher, X. X. Zheng

Research output: Contribution to journalArticle

Abstract

Vascularized composite allografts (VCAs) are unique among transplanted organs in that they are composed of multiple tissues with disparate antigenic and immunologic properties. As the predominant indications for VCAs are non-life-threatening conditions, there is an immediate need to develop tolerance induction strategies and to elucidate the mechanisms of VCA rejection and tolerance using VCA-specific animal models. In this study, we explore the effects of in vitro induced donor antigen-specific CD4-CD8 - double negative (DN) Treg-based therapy, in a fully MHC mismatched mouse VCA such as a vascularized osteomyocutaneous as compared to a non-VCA such as a full thickness skin (FTS) transplantation model to elucidate the unique features of VCA rejection and tolerance. We demonstrate that combined therapy with antigen-induced CD4 derived DN Tregs and a short course of anti-lymphocyte serum, rapamycin and IL-2/Fc fusion protein results in donor-specific tolerance to VCA, but not FTS allografts. Macrochimerism was detected in VCA but not FTS allograft recipients up to >60 days after transplantation. Moreover, a significant increase of CD4+Foxp3+ Tregs was found in the peripheral blood of tolerant VCA recipients. These data suggest that VCA are permissive to tolerance induced by DN Treg-based induction therapy. This study demonstrates that vascularized osteomyocutaneous allografts are permissive to tolerance by inductionbased immunomodulatory therapy, and ex vivo alloantigen-induced CD4+ T cell - derived DN Tregs may provide an opportunity to develop novel strategies for transplant tolerance.

Original languageEnglish (US)
Pages (from-to)2161-2168
Number of pages8
JournalAmerican Journal of Transplantation
Volume13
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Composite Tissue Allografts
Immunomodulation
Allografts
Transplantation Tolerance
CD4 Antigens
Skin
Skin Transplantation
Isoantigens
Sirolimus
Interleukin-2

Keywords

  • Chimerism
  • composite tissue allografts
  • regulatory T cells
  • tolerance
  • vascularized bone marrow transplant

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy. / Lin, C. H.; Zhang, W.; Ng, T. W.; Zhang, D.; Jiang, J.; Pulikkottil, B.; Lakkis, F.; Gorantla, V. S.; Lee, W P Andrew; Brandacher, Gerald; Zheng, X. X.

In: American Journal of Transplantation, Vol. 13, No. 8, 08.2013, p. 2161-2168.

Research output: Contribution to journalArticle

Lin, CH, Zhang, W, Ng, TW, Zhang, D, Jiang, J, Pulikkottil, B, Lakkis, F, Gorantla, VS, Lee, WPA, Brandacher, G & Zheng, XX 2013, 'Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy', American Journal of Transplantation, vol. 13, no. 8, pp. 2161-2168. https://doi.org/10.1111/ajt.12275
Lin, C. H. ; Zhang, W. ; Ng, T. W. ; Zhang, D. ; Jiang, J. ; Pulikkottil, B. ; Lakkis, F. ; Gorantla, V. S. ; Lee, W P Andrew ; Brandacher, Gerald ; Zheng, X. X. / Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy. In: American Journal of Transplantation. 2013 ; Vol. 13, No. 8. pp. 2161-2168.
@article{adb2363cc6044020b4384579f7b1cd8e,
title = "Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy",
abstract = "Vascularized composite allografts (VCAs) are unique among transplanted organs in that they are composed of multiple tissues with disparate antigenic and immunologic properties. As the predominant indications for VCAs are non-life-threatening conditions, there is an immediate need to develop tolerance induction strategies and to elucidate the mechanisms of VCA rejection and tolerance using VCA-specific animal models. In this study, we explore the effects of in vitro induced donor antigen-specific CD4-CD8 - double negative (DN) Treg-based therapy, in a fully MHC mismatched mouse VCA such as a vascularized osteomyocutaneous as compared to a non-VCA such as a full thickness skin (FTS) transplantation model to elucidate the unique features of VCA rejection and tolerance. We demonstrate that combined therapy with antigen-induced CD4 derived DN Tregs and a short course of anti-lymphocyte serum, rapamycin and IL-2/Fc fusion protein results in donor-specific tolerance to VCA, but not FTS allografts. Macrochimerism was detected in VCA but not FTS allograft recipients up to >60 days after transplantation. Moreover, a significant increase of CD4+Foxp3+ Tregs was found in the peripheral blood of tolerant VCA recipients. These data suggest that VCA are permissive to tolerance induced by DN Treg-based induction therapy. This study demonstrates that vascularized osteomyocutaneous allografts are permissive to tolerance by inductionbased immunomodulatory therapy, and ex vivo alloantigen-induced CD4+ T cell - derived DN Tregs may provide an opportunity to develop novel strategies for transplant tolerance.",
keywords = "Chimerism, composite tissue allografts, regulatory T cells, tolerance, vascularized bone marrow transplant",
author = "Lin, {C. H.} and W. Zhang and Ng, {T. W.} and D. Zhang and J. Jiang and B. Pulikkottil and F. Lakkis and Gorantla, {V. S.} and Lee, {W P Andrew} and Gerald Brandacher and Zheng, {X. X.}",
year = "2013",
month = "8",
doi = "10.1111/ajt.12275",
language = "English (US)",
volume = "13",
pages = "2161--2168",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy

AU - Lin, C. H.

AU - Zhang, W.

AU - Ng, T. W.

AU - Zhang, D.

AU - Jiang, J.

AU - Pulikkottil, B.

AU - Lakkis, F.

AU - Gorantla, V. S.

AU - Lee, W P Andrew

AU - Brandacher, Gerald

AU - Zheng, X. X.

PY - 2013/8

Y1 - 2013/8

N2 - Vascularized composite allografts (VCAs) are unique among transplanted organs in that they are composed of multiple tissues with disparate antigenic and immunologic properties. As the predominant indications for VCAs are non-life-threatening conditions, there is an immediate need to develop tolerance induction strategies and to elucidate the mechanisms of VCA rejection and tolerance using VCA-specific animal models. In this study, we explore the effects of in vitro induced donor antigen-specific CD4-CD8 - double negative (DN) Treg-based therapy, in a fully MHC mismatched mouse VCA such as a vascularized osteomyocutaneous as compared to a non-VCA such as a full thickness skin (FTS) transplantation model to elucidate the unique features of VCA rejection and tolerance. We demonstrate that combined therapy with antigen-induced CD4 derived DN Tregs and a short course of anti-lymphocyte serum, rapamycin and IL-2/Fc fusion protein results in donor-specific tolerance to VCA, but not FTS allografts. Macrochimerism was detected in VCA but not FTS allograft recipients up to >60 days after transplantation. Moreover, a significant increase of CD4+Foxp3+ Tregs was found in the peripheral blood of tolerant VCA recipients. These data suggest that VCA are permissive to tolerance induced by DN Treg-based induction therapy. This study demonstrates that vascularized osteomyocutaneous allografts are permissive to tolerance by inductionbased immunomodulatory therapy, and ex vivo alloantigen-induced CD4+ T cell - derived DN Tregs may provide an opportunity to develop novel strategies for transplant tolerance.

AB - Vascularized composite allografts (VCAs) are unique among transplanted organs in that they are composed of multiple tissues with disparate antigenic and immunologic properties. As the predominant indications for VCAs are non-life-threatening conditions, there is an immediate need to develop tolerance induction strategies and to elucidate the mechanisms of VCA rejection and tolerance using VCA-specific animal models. In this study, we explore the effects of in vitro induced donor antigen-specific CD4-CD8 - double negative (DN) Treg-based therapy, in a fully MHC mismatched mouse VCA such as a vascularized osteomyocutaneous as compared to a non-VCA such as a full thickness skin (FTS) transplantation model to elucidate the unique features of VCA rejection and tolerance. We demonstrate that combined therapy with antigen-induced CD4 derived DN Tregs and a short course of anti-lymphocyte serum, rapamycin and IL-2/Fc fusion protein results in donor-specific tolerance to VCA, but not FTS allografts. Macrochimerism was detected in VCA but not FTS allograft recipients up to >60 days after transplantation. Moreover, a significant increase of CD4+Foxp3+ Tregs was found in the peripheral blood of tolerant VCA recipients. These data suggest that VCA are permissive to tolerance induced by DN Treg-based induction therapy. This study demonstrates that vascularized osteomyocutaneous allografts are permissive to tolerance by inductionbased immunomodulatory therapy, and ex vivo alloantigen-induced CD4+ T cell - derived DN Tregs may provide an opportunity to develop novel strategies for transplant tolerance.

KW - Chimerism

KW - composite tissue allografts

KW - regulatory T cells

KW - tolerance

KW - vascularized bone marrow transplant

UR - http://www.scopus.com/inward/record.url?scp=84881369551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881369551&partnerID=8YFLogxK

U2 - 10.1111/ajt.12275

DO - 10.1111/ajt.12275

M3 - Article

C2 - 23718897

AN - SCOPUS:84881369551

VL - 13

SP - 2161

EP - 2168

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 8

ER -